DrugDigest  
 
    Search
 
  Drugs & Herbs
  Conditions
  News & Reviews
7 Steps to Safety
Check For Savings
Senior Corner
Glossary
eBulletins
Home
Express Scripts Member?

Health Conditions

Inflammatory Bowel Disease

References

  1. Brandt LJ, Steiner-Grossman P, eds. Treating IBD: A Patient's Guide to the Medical and Surgical Management of Inflammatory Bowel Disease. New York: Raven Press; 1989.

  2. Chande N, McDonald JW, MacDonald JK. Unfractionated or low-molecular-weight heparin for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2008; 2:CD006774.

  3. Dipiro JT, Schade RR. Inflammatory Bowel Disease. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York: McGraw-Hill; 2005: 649-664.

  4. Feldman M. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 7th ed. New York: Elsevier; 2002.

  5. Hu M, Peppercorn MA. MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis. Expert Opin Pharmacother. 2008; 9(6):1049-58.

  6. Hutas G. Golimumab, a fully human monoclonal antibody against TNFalpha. Curr Opin Mol Ther. 2008; 10(4):393-406.

  7. Lewis JD, Lichtenstein GR, Deren JJ, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008; 134(3):688-95.

  8. National Digestive Diseases Information Clearinghouse. Ulcerative Clearinghouse. Available at: http://digestive.niddk.nih.gov/ddiseases/pubs/colitis/index.htm. Accessed August 2007 and September 2008.

  9. Pastorelli L, Saibeni S, Spina L, et al. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2008; 28(5):581-5.

  10. Pham M, Lemberg DA, Day AS. Probiotics: sorting the evidence from the myths. Med J Aust. 2008 Mar; 188(5):304-8.

  11. Podolsky DK. Inflammatory Bowel Disease. New England Journal of Medicine. 2002(347):417-429.

  12. Wall G. Lower Gastrointestinal Disorders. In: Koda-Kimble MA, et al. Applied Therapeutics: The Clinical Use of Drugs. 8th ed. Philadelphia: Lippincott, Williams and Wilkins; 2005: 28-1 to 28-23.

    << Back


Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.

  Learn About

Introduction

What is it?

What causes it?

Who has it?

What are the risk factors?

What are the symptoms?

How is it treated?

What is on the horizon?

References



Printable Version     Recommend this page to a friend